Eli Lilly recalls single lot of emergency kit for severe hypoglycemia

Michael Walter | | Cardiovascular Business | Heart Health
Recall

Eli Lilly and Company is recalling a single lot of its Glucagon Emergency Kit for Low Blood Sugar due to potential issues with the product’s potency.

The emergency kits are designed to help treat severe hypoglycemia in both children and adults with severe low blood sugar. According to a complaint the company received, a vial of Glucagon was found in liquid form instead of the expected powder form.

This issue, Eli Lilly noted, “could be related to the manufacturing process” and the product “may fail to treat severe low blood sugar.”

The affected lot is D239382D, and its expiration date is April 2022.

“Lilly is deeply committed to manufacturing high-quality medicines for patients who need them, and the safety and quality of our products is our highest priority,” according to a statement from Eli Lilly. “We take our obligations seriously and have rigorous quality systems in place to ensure compliance with stringent regulatory requirements.”

The FDA also shared this information with consumers on its website.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Medtronic receives key FDA clearance, launches new diabetes system
Martha Gulati highlights 'exciting' progress in preventive cardiology
Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment
Cardiologist examines the latest breakthroughs in coronary inflammation research
Tirzepatide linked to significant weight loss, ‘impressive’ diabetes prevention after 3 years
No-contact blood pressure and diabetes screening with AI shows promise

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."